A New Lifeline for Long-Term HIV Survivors: FDA Approves ViiV’s Rukobia
The landscape of HIV treatment continues to evolve, and a significant milestone has just been reached with the FDA’s approval of Rukobia (fostemsavir), a novel therapy from ViiV Healthcare. Reported…